Despite being given days to live, Charlie Lock still has lots of things he wants to achieve.
Trending
- East Surrey and Crawley Hospitals increase scalp cooling for cancer patients
- MICAL2 as a key effector of β-catenin signaling driving melanoma progression and therapeutic resistance
- Spatial analysis of head and neck cancer identifies two ecosystems with distinct modes of epithelial-to-mesenchymal transition
- NCAM1 potentiates small cell lung cancer stemness and resistance to NK cell-mediated cytotoxicity
- Loss of CD44 re-educates pancreatic cancer-associated fibroblasts modulating their fibrotic and immunosuppressive functions
- Defining the Objectives of an Analysis of Tarlatamab in Brain Metastases
- Imbalanced p53–RB signaling triggers cGAS–STING–mediated immune activation in early oral cancer development
- What Are The Biggest Misconceptions About CAR T Cells in Multiple Myeloma?
Sunday, August 16
